State Street SPDR S&P Pharmaceuticals ETF (XPH) closed at $65.36 on November 4, 2026, up 1.6% from the previous close, on volume of 189,750 shares (30-day average 221,383).
Data as of November 4, 2026.
4-Nov-2026
No headlines found.
No press releases found.
No news found.
State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS").
State Street SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.
As of November 4, 2026, XPH stock price climbed to $65.36 with 189,750 million shares trading.
XPH has a beta of 0.77, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.19 to the broad based SPY ETF.
XPH has a market cap of $490.22 million. This is considered a Small Cap stock.
In the last 3 years, XPH traded as high as $74.35 and as low as $34.67.
XPH has outperformed the market in the last year with a price return of +32.1% while the SPY ETF gained +13.3%. However, in the short term, XPH had mixed performance relative to the market. It has underperformed in the last 3 months, returning -4.1% vs +1.5% return in SPY. But in the last 2 weeks, XPH shares have fared better than the market returning +1.9% compared to SPY -0.3%.
XPH support price is $63.26 and resistance is $65.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH shares will trade within this expected range on the day.
